EGFR and lung cancer: A separate study in lung cancer cells harboring epidermal growth factor receptor (EGFR)-activating mutations found that preferential expression of DDX3X induced a cancer stem cell-like phenotype, increasing EMT as well as a loss of sensitivity to EGFR-tyrosine kinase inhibitors [90].